Sign in

CIK 0001346830

  • Non-accelerated filer
  • Smaller reporting company

Tvardi Therapeutics, Inc.

Sign in to watch
Ticker
TVRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 713-489-8654
Business address
3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
Former names
Cara Therapeutics, Inc., Cara Therapeutics Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-09 Shiff Susan Ph.D. Director Grant or award · Stock Option (right to buy) +6,000 6,000
2026-06-09 HALL WALLACE L JR Director Grant or award · Stock Option (right to buy) +6,000 6,000
2026-06-09 Smith Cynthia Director Grant or award · Stock Option (right to buy) +6,000 6,000
2026-06-09 Shah Sujal Director Grant or award · Stock Option (right to buy) +6,000 6,000
2026-06-09 WYZGA MICHAEL S Director Grant or award · Stock Option (right to buy) +6,000 6,000
2026-01-29 Conn Avi Daniel Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +45,000 45,000
2026-01-29 O'Brien Stephen Paul Principal Accounting Officer Grant or award · Employee Stock Option (right to buy) +15,000 15,000
2026-01-29 Alibhai Imran Nizamudin Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +115,000 115,000
2026-01-29 Kauh John Saewook M.D. Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +45,000 45,000
2025-12-16 Conn Avi Daniel Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +17,500 17,500
2025-12-16 O'Brien Stephen Paul Principal Accounting Officer Grant or award · Employee Stock Option (right to buy) +4,000 4,000
2025-12-16 Alibhai Imran Nizamudin Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +47,500 47,500
2025-12-16 Kauh John Saewook M.D. Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +17,500 17,500
2025-07-07 Tweardy Samuel David 10% owner Other disposition −315,658 0
2025-07-07 Tweardy Samuel David 10% owner Other disposition −315,658 0
2025-04-17 Larson Jeffrey Leroy SVP, Research & Development Grant or award · Employee Stock Option (right to buy) +10,820 10,820
2025-04-17 O'Brien Stephen Paul Principal Accounting Officer Grant or award · Employee Stock Option (right to buy) +7,213 7,213
2025-04-17 Chen Yixin VP, Chem, Mfg and Ctrls Grant or award · Employee Stock Option (right to buy) +7,213 7,213
2025-04-17 Conn Avi Daniel Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +43,547 43,547
2025-04-17 Kauh John Saewook M.D. Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +36,210 36,210

Page 1 of 7 · 123 trades